Monopar Therapeutics Statistics
NASDAQ: MNPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
83.78+4.21 (+5.29%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Monopar Therapeutics by the numbers
Monopar Therapeutics has a market capitalization of $562.3 million based on 6.71M shares outstanding. With trailing EPS of $-2.20, Monopar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.8% below its 50-day average and 9.4% above its 200-day average.
Average daily trading volume is 218.50K shares, or about $18.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MNPR valuation vs. peer median
| Metric | MNPR | Peer median | Difference |
|---|---|---|---|
| Market cap | $562.35M | $521.84M | +8% |
| Avg. volume | 218.50K | 561.96K | -61% |
Peer median across 8 companies: BLSM, OCS, MPLT, NGNE, ALT, PHAT, DRUG, CTMX.
Valuation
- Market cap
- $562.35M
- EPS (TTM)
- $-2.20
- Shares outstanding
- 6.71M
Price and trading
- Previous close
- 79.57
- Open
- 78.28
- Day range
- 78.00 – 85.03
- 52-week range
- 50.07 – 124.82
- 52-week change
- -14.96%
- 50-day moving average
- 105.85
- Beta
- —
- Volume
- 107.03K
- Average volume
- 218.50K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 562.35M
- Forward Pe
- -43.73
- Eps
- -2.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 124.82
- Week52 Low
- 50.07
- Avg Volume
- 218.50K
- Shares Outstanding
- 6.71M
- Ma50
- 105.85
- Ma200
- 76.56
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -32.88%
- Pct From52w Low
- 67.33%